| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |